Gut Metabolite TMAO Induces Synaptic Plasticity Deficits by Promoting Endoplasmic Reticulum Stress

Overview

Journal Front Mol Neurosci

Specialty Molecular Biology

Date 2020 Sep 9

PMID 32903435

Citations 44

Authors

Manoj Govindarajulu

Priyanka D Pinky

Ian Steinke

Jenna Bloemer

Sindhu Ramesh

Thiruchelvan Kariharan

Robert T Rella

Subhrajit Bhattacharya

Muralikrishnan Dhanasekaran

Vishnu Suppiramaniam

Rajesh H Amin

Affiliations

Soon will be listed here.

Abstract

Dysbiosis of gut microbiota is strongly associated with metabolic diseases including diabetes mellitus, obesity, and cardiovascular disease. Recent studies indicate that Trimethylamine N-oxide (TMAO), a gut microbe-dependent metabolite is implicated in the development of age-related cognitive decline. However, the mechanisms of the impact of TMAO on neuronal function has not been elucidated. In the current study, we investigated the relationship between TMAO and deficits in synaptic plasticity in an Alzheimer's model (3×Tg-AD) and insulin resistance (Leptin deficient db/db) mouse by measuring plasma and brain levels of TMAO. We observed increased TMAO levels in the plasma and brain of both db/db and 3×Tg-AD mice in comparison to wild-type mice. Besides, TMAO levels further increased as mice progressed in age. Deficits in synaptic plasticity, in the form of reduced long-term potentiation (LTP), were noted in both groups of mice in comparison to wild-type mice. To further explore the impact of TMAO on neuronal function, we utilized an model by incubating wild-type hippocampal brain slices with TMAO and found impaired synaptic transmission. We observed that TMAO induced the PERK-EIF2α-ER stress signaling axis in TMAO treated slices as well as in both db/db and 3×Tg-AD mice. Lastly, we also observed altered presynaptic and reduced postsynaptic receptor expression. Our findings suggest that TMAO may induce deficits in synaptic plasticity through the ER stress-mediated PERK signaling pathway. Our results offer novel insight into the mechanism by which TMAO may induce cognitive deficits by promoting ER stress and identifies potential targets for therapeutic intervention.

Citing Articles

Trymethylamine-N-oxide, a gut-derived metabolite, induces myofibroblastic activation of valvular interstitial cells through endoplasmic reticulum stress.

Sudi S, Suresh S, Kolli T, Porras A bioRxiv. 2025; .

PMID: 39975143 PMC: 11839121. DOI: 10.1101/2025.02.06.636980.

The Role of Gut Microbiota-Derived Trimethylamine N-Oxide in the Pathogenesis and Treatment of Mild Cognitive Impairment.

Xie H, Jiang J, Cao S, Xu X, Zhou J, Zhang R Int J Mol Sci. 2025; 26(3).

PMID: 39941141 PMC: 11818489. DOI: 10.3390/ijms26031373.

TMAO is involved in sleep deprivation-induced cognitive dysfunction through regulating astrocytic cholesterol metabolism via SREBP2.

Zhu S, Wang Y, Li Y, Li N, Zheng Y, Li Q Front Mol Neurosci. 2024; 17:1499591.

PMID: 39669439 PMC: 11634841. DOI: 10.3389/fnmol.2024.1499591.

Correlation Between Regulation of Intestinal Flora by Danggui-Shaoyao-San and Improvement of Cognitive Impairment in Mice With Alzheimer's Disease.

Wang Y, Ding P, Zhang K, Xu X, Li H Brain Behav. 2024; 14(11):e70110.

PMID: 39482855 PMC: 11527834. DOI: 10.1002/brb3.70110.

Deficiency of flavin-containing monooxygenase 3 protects kidney function after ischemia-reperfusion in mice.

Wang J, Wang W, Zhang J, Xiao F, Li Z, Xu P Commun Biol. 2024; 7(1):1054.

PMID: 39191965 PMC: 11350001. DOI: 10.1038/s42003-024-06718-0.

References

Costa-Mattioli M, Gobert D, Harding H, Herdy B, Azzi M, Bruno M . Translational control of hippocampal synaptic plasticity and memory by the eIF2alpha kinase GCN2. Nature. 2005; 436(7054):1166-73. PMC: 1464117. DOI: 10.1038/nature03897. View

Boyce M, Bryant K, Jousse C, Long K, Harding H, Scheuner D . A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science. 2005; 307(5711):935-9. DOI: 10.1126/science.1101902. View

Bliss T, Collingridge G . A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993; 361(6407):31-9. DOI: 10.1038/361031a0. View

Jia J, Dou P, Gao M, Kong X, Li C, Liu Z . Assessment of Causal Direction Between Gut Microbiota-Dependent Metabolites and Cardiometabolic Health: A Bidirectional Mendelian Randomization Analysis. Diabetes. 2019; 68(9):1747-1755. DOI: 10.2337/db19-0153. View

Bloemer J, Pinky P, Smith W, Bhattacharya D, Chauhan A, Govindarajulu M . Adiponectin Knockout Mice Display Cognitive and Synaptic Deficits. Front Endocrinol (Lausanne). 2019; 10:819. PMC: 6886372. DOI: 10.3389/fendo.2019.00819. View

Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C . Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2016; 49:60-68. DOI: 10.1016/j.neurobiolaging.2016.08.019. View

Klann E, Sweatt J . Altered protein synthesis is a trigger for long-term memory formation. Neurobiol Learn Mem. 2007; 89(3):247-59. PMC: 2323606. DOI: 10.1016/j.nlm.2007.08.009. View

Halliday M, Mallucci G . Review: Modulating the unfolded protein response to prevent neurodegeneration and enhance memory. Neuropathol Appl Neurobiol. 2015; 41(4):414-27. PMC: 5053297. DOI: 10.1111/nan.12211. View

Terashima A, Suh Y, Isaac J . The AMPA Receptor Subunit GluA1 is Required for CA1 Hippocampal Long-Term Potentiation but is not Essential for Synaptic Transmission. Neurochem Res. 2017; 44(3):549-561. DOI: 10.1007/s11064-017-2425-3. View

10.

Adler B, Yarchoan M, Hwang H, Louneva N, Blair J, Palm R . Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition. Neurobiol Aging. 2013; 35(4):793-801. DOI: 10.1016/j.neurobiolaging.2013.10.076. View

11.

Fung T . The microbiota-immune axis as a central mediator of gut-brain communication. Neurobiol Dis. 2019; 136:104714. DOI: 10.1016/j.nbd.2019.104714. View

12.

Kariharan T, Nanayakkara G, Parameshwaran K, Bagasrawala I, Ahuja M, Abdel-Rahman E . Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression. Neurobiol Aging. 2014; 36(3):1451-61. DOI: 10.1016/j.neurobiolaging.2014.09.028. View

13.

Gao X, Liu X, Xu J, Xue C, Xue Y, Wang Y . Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet. J Biosci Bioeng. 2014; 118(4):476-81. DOI: 10.1016/j.jbiosc.2014.03.001. View

14.

Costa-Mattioli M, Sossin W, Klann E, Sonenberg N . Translational control of long-lasting synaptic plasticity and memory. Neuron. 2009; 61(1):10-26. PMC: 5154738. DOI: 10.1016/j.neuron.2008.10.055. View

15.

Chen S, Henderson A, Petriello M, Romano K, Gearing M, Miao J . Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction. Cell Metab. 2019; 30(6):1141-1151.e5. DOI: 10.1016/j.cmet.2019.08.021. View

16.

DiNicolantonio J, McCarty M, OKeefe J . Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic insulin resistance. Open Heart. 2019; 6(1):e000890. PMC: 6443140. DOI: 10.1136/openhrt-2018-000890. View

17.

Duran-Aniotz C, Martinez G, Hetz C . Memory loss in Alzheimer's disease: are the alterations in the UPR network involved in the cognitive impairment?. Front Aging Neurosci. 2014; 6:8. PMC: 3906588. DOI: 10.3389/fnagi.2014.00008. View

18.

Fung T, Olson C, Hsiao E . Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci. 2017; 20(2):145-155. PMC: 6960010. DOI: 10.1038/nn.4476. View

19.

Luscher C, Malenka R . NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD). Cold Spring Harb Perspect Biol. 2012; 4(6). PMC: 3367554. DOI: 10.1101/cshperspect.a005710. View

20.

DErrico A, Prestori F, DAngelo E . Differential induction of bidirectional long-term changes in neurotransmitter release by frequency-coded patterns at the cerebellar input. J Physiol. 2009; 587(Pt 24):5843-57. PMC: 2808544. DOI: 10.1113/jphysiol.2009.177162. View